Evidence map›Paper›PMID 34585096›Full record

ArticleTurkish journal of surgery2021

Primary anorectal malignant melanomas: retrospective analysis of 11 cases in a single center.

Erol Pişkin, Osman Aydın, Abdullah Şenlikçi, Mehmet Yiğit Özgün, Volkan Öter, Erdal Birol Bostancı

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Erol PişkinClinic of Surgical Gastroenterology, Ankara City Hospital, Ankara, Turkey.
Osman AydınClinic of Surgical Gastroenterology, Ankara City Hospital, Ankara, Turkey.
Abdullah ŞenlikçiClinic of Surgical Gastroenterology, Ankara Training and Research Hospital, Ankara, Turkey.
Mehmet Yiğit ÖzgünClinic of Surgical Gastroenterology, Ankara City Hospital, Ankara, Turkey.
Volkan ÖterClinic of Surgical Gastroenterology, Ankara City Hospital, Ankara, Turkey.
Erdal Birol BostancıClinic of Surgical Gastroenterology, Ankara City Hospital, Ankara, Turkey.
Memorial Ankara Hospital · TRMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAnorectal malignant melanoma is a rare tumor with poor prognosis. In this study, it was aimed to present our surgical results by reviewing the literature retrospectively in 11 patients who underwent surgery for ARMM in our clinic. MATERIAL AND

methodsThe patients who underwent surgery for anorectal malignant melanoma in Yuksek İhtisas Training and Research Hospital between 2007-2018 were included in the study.

resultsFour patients were males and seven were females. Mean age was 54.18. The tumor was in the rectum in 4 cases, in the anorectal region in 3 cases and in the anal canal in 4 cases. Wide local excision was performed in 3 cases and APR was performed in 8 cases. Four of the cases were stage I, 6 were stage II and 1 was stage III. Mean tumor size was 4.73 cm, and mean tumor depth was 13.6 mm. Mean number of metastatic lymph nodes was 10.37. Median survival was 12 months.

conclusionAnorectal malignant melanoma is a type of tumor diagnosed in late and advanced stages due to lack of specific findings. Although ARMM is rare, when rectal bleeding, pain, hemorrhoids and changes in bowel habits are observed, ARMM should be kept in mind.

Indexed as

abdominoperineal resectionAnorectal malignant melanomaprognosiswide local excision

Identifiers

PMID34585096
PMCPMC8448560
OpenAlexW3156175361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.